Adaptive Biotechnologies Corporation

ADPT

NASDAQ

Healthcare

Biotechnology

Seattle, WA, US619 employeesadaptivebiotech.com

$14.84

+0.41(2.8%)

52W $6.83 – $20.46

AI-generated

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Revenue breakdown: Service (57.5%), Immune Medicine Service Revenue (16%), Collaboration Revenue (13.1%).

$2.3BMkt Cap

$279MRev TTM

-$60MNI TTM

-35.2xP/E TTM

Latest Earnings

10-K

FY FY2025Feb 25, 2026

10-K for FY2025 was filed on 2026-02-26. AI summary is not available yet.

Read full analysis View SEC Filing

What Changed Recently

Financial Results

Feb 4, 2026

and the press release attached as Exhibit 99.1 hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as am

View filing →

Financial Results

Jan 11, 2026

and the press release attached as Exhibit 99.1 hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as am

View filing →

View all recent events →

Fundamentals

How The Business Makes Money

Revenue by Segment

Service57.5%($429M)

Immune Medicine Service Revenue16%($119M)

Collaboration Revenue13.1%($97M)

Service And Licensing Revenue9.2%($68M)

Regulatory Milestone Revenue4.3%($32M)

Analyst View

Peer Companies

Company	Price	Change	Market Cap	P/E
SRRKScholar Rock Holding Corp...	$50.27	+1.87%	$5.8B	-13.3
CDTXCDTX	$221.38	+0.00%	$5.6B	—
LEGNLegend Biotech Corporatio...	$19.10	+0.26%	$3.5B	-10.7
CPRXCatalyst Pharmaceuticals,...	$24.70	-0.48%	$3.0B	13.3
TARSTarsus Pharmaceuticals, I...	$69.90	-0.46%	$3.0B	-41.3
IDYAIDEAYA Biosciences, Inc.	$32.60	+0.37%	$2.9B	-24.7
BEAMBeam Therapeutics Inc.	$24.65	+1.78%	$2.5B	-32.4
IRONDisc Medicine, Inc.	$65.22	+0.68%	$2.5B	-9.8

Company Profile

CIK0001478320

ISINUS00650F1093

CUSIP00650F109

Phone206 659 0067

Address1165 Eastlake Avenue East, Seattle, WA, 98109, US

SEC EDGAR